Capital Research Global Investors’s Encompass Health EHC Stock Holding History

Capital Research Global Investors’s Portfolio EHC Stock Details EHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$78.7M	Buy	813,732 +216,430	+36%	+$22.2M	0.01%	327
2025 Q4	$63.4M	Sell	597,302 -5,219	-0.9%	-$605K	0.01%	335
2025 Q3	$76.5M	Sell	602,521 -41,712	-6%	-$4.97M	0.01%	316
2025 Q2	$79M	Hold	644,233	–	–	0.02%	308
2025 Q1	$65.2M	Sell	644,233 -136,696	-18%	-$13.3M	0.01%	338
2024 Q4	$72.1M	Sell	780,929 -6,920	-0.9%	-$679K	0.01%	333
2024 Q3	$76.1M	Hold	787,849	–	–	0.02%	309
2024 Q2	$67.6M	Hold	787,849	–	–	0.01%	312
2024 Q1	$65.1M	Hold	787,849	–	–	0.01%	322
2023 Q4	$52.6M	Hold	787,849	–	–	0.01%	319
2023 Q3	$52.9M	Hold	787,849	–	–	0.01%	320
2023 Q2	$53.3M	Hold	787,849	–	–	0.01%	321
2023 Q1	$42.6M	Sell	787,849 -694,037	-47%	-$40.4M	0.01%	336
2022 Q4	$88.6M	Sell	1,481,886 -101,147	-6%	-$5.5M	0.03%	282
2022 Q3	$71.6M	Buy	1,583,033 +95,724	+6%	+$4.79M	0.02%	288
2022 Q2	$66.3M	Buy	1,487,309 +684,610	+85%	+$35.1M	0.02%	303
2022 Q1	$45.4M	Buy	802,699 +146,042	+22%	+$7.62M	0.01%	371
2021 Q4	$34.1M	Hold	656,657	–	–	0.01%	392
2021 Q3	$39.2M	Hold	656,657	–	–	0.01%	381
2021 Q2	$40.8M	Hold	656,657	–	–	0.01%	383
2021 Q1	$42.8M	Hold	656,657	–	–	0.01%	372
2020 Q4	$43.2M	Hold	656,657	–	–	0.01%	352
2020 Q3	$33.9M	Hold	656,657	–	–	0.01%	347
2020 Q2	$32.4M	Hold	656,657	–	–	0.01%	348
2020 Q1	$33.4M	Sell	656,657 -644,841	-50%	-$37.2M	0.01%	312
2019 Q4	$71.7M	Sell	1,301,498 -314,250	-19%	-$17.1M	0.02%	293
2019 Q3	$81.3M	Hold	1,615,748	–	–	0.03%	282
2019 Q2	$81.4M	Buy	1,615,748 +333,105	+26%	+$16.2M	0.03%	277
2019 Q1	$59.6M	Hold	1,282,643	–	–	0.02%	308
2018 Q4	$63M	Hold	1,282,643	–	–	0.02%	292
2018 Q3	$79.5M	Hold	1,282,643	–	–	0.02%	304
2018 Q2	$69.1M	Buy	1,282,643 +187,796	+17%	+$9.39M	0.02%	315
2018 Q1	$49.8M	Buy	+1,094,847	New	+$46.9M	0.01%	344

Other funds holding EHC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Capital Research Global Investors's EHC Position: Q1 2026 in Review

Capital Research Global Investors increased its Encompass Health (EHC) stake by 36% in Q1 2026, buying an estimated $22.2M and bringing the position to 813,732 shares worth $78.7M. The position accounts for 0.01% of the portfolio, ranked #327.

Capital Research Global Investors first reported a position in EHC in Q1 2018 and has held it in 33 quarters since. The position peaked at $88.6M in Q4 2022. 578 funds tracked by Wall St. Rank hold EHC as of Q1 2026.

Capital Research Global Investors held 813,732 shares of Encompass Health worth $78.7M as of Q1 2026.
Capital Research Global Investors bought 216,430 Encompass Health shares in Q1 2026, an estimated $22.2M.
Encompass Health made up 0.01% of Capital Research Global Investors's portfolio in Q1 2026, its #327 holding.
Capital Research Global Investors first reported a position in Encompass Health in Q1 2018 and has held it in 33 quarters since.
Capital Research Global Investors's Encompass Health position peaked at $88.6M in Q4 2022.
578 funds tracked by Wall St. Rank held Encompass Health as of Q1 2026.

Based on Capital Research Global Investors's 13F filing for Q1 2026, filed 13 May 2026.